School of Medicine, Department of Radiation Oncology, University of Maryland, Baltimore, MD, USA.
Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Med Phys. 2017 Dec;44(12):e446-e458. doi: 10.1002/mp.12611. Epub 2017 Nov 1.
Microwave imaging (MI) technology has come a long way to introduce a noninvasive, inexpensive, fast, convenient, and safe screening tool for clinical breast monitoring. However, there is a niche between the existing understanding of MI by engineers versus clinicians. Our manuscript targets that niche and highlights the state of the art in MI technology compared to the existing breast cancer detection modalities (mammography, ultrasound, molecular imaging, and magnetic resonance). The significance of our review article is in consolidation of up-to-date breast clinician views with the practical needs and engineering challenges of a novel breast screening modality. We summarize breast tissue abnormalities and highlight the benefits as well as potential drawbacks of the MI as a cancer detection methodology. Our goal is to present an article that MI researchers as well as practitioners in the field can use to assess the viability of the MI technology as a competing or complementary modality to the existing means of breast cancer screening.
微波成象（MI）技术已经取得了长足的进步，为临床乳房监测引入了一种非侵入性、廉价、快速、方便和安全的筛查工具。然而，工程师和临床医生对 MI 的现有理解之间存在一个差距。我们的论文旨在填补这一空白，并将 MI 技术与现有的乳腺癌检测方式（乳房 X 光摄影、超声、分子成像和磁共振）进行比较，突出其最新技术水平。我们的综述文章的意义在于将最新的乳房临床医生的观点与一种新型乳房筛查方式的实际需求和工程挑战相结合。我们总结了乳房组织异常，并强调了 MI 作为癌症检测方法的优势以及潜在的缺点。我们的目标是提供一篇文章，MI 研究人员和该领域的从业者可以用它来评估 MI 技术作为乳腺癌筛查现有手段的竞争或补充手段的可行性。
